Donald E G Griesdale1, Victoria Örtenwall2, Monica Norena3, Hubert Wong4, Mypinder S Sekhon5, Leif Kolmodin5, William R Henderson5, Peter Dodek6. 1. Division of Critical Care Medicine, Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada; Department of Anesthesiology, Pharmacology and Therapeutics University of British Columbia, Vancouver, British Columbia, Canada; Centre for Clinical Epidemiology and Evaluation, Vancouver Coastal Health Research Institute, Vancouver British Columbia, Canada. Electronic address: donald.griesdale@vch.ca. 2. Department of Anaesthesiology and Critical Care Medicine, Lund University, Lund, Sweden. 3. Centre for Health Evaluation & Outcome Sciences, Providence Health Care and University of British Columbia, Vancouver, British Columbia, Canada. 4. Centre for Health Evaluation & Outcome Sciences, Providence Health Care and University of British Columbia, Vancouver, British Columbia, Canada; School of Population and Public Health, University of British Columbia, Vancouver, British Columbia, Canada. 5. Division of Critical Care Medicine, Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada. 6. Division of Critical Care Medicine, Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada; Centre for Health Evaluation & Outcome Sciences, Providence Health Care and University of British Columbia, Vancouver, British Columbia, Canada.
Abstract
PURPOSE: The aims of this study are to assess adherence to the Brain Trauma Foundation (BTF) cerebral perfusion pressure (CPP) guidelines and to determine if adherence is associated with mortality in patients who have a severe traumatic brain injury. MATERIALS AND METHODS: Retrospective cohort study of 127 patients admitted to one intensive care unit between 2006 and 2012. Adherence to BTF guidelines was measured as the time that the CPP was within 50 to 70 mm Hg divided by the total time of CPP monitoring (CPP time index). RESULTS: The percentage of time that the CPP was within the recommended range was 31.6% (SD, 22.2); CPP was greater than 70 mm Hg for 63.9% (SD, 26.2) of the time and less than 50 mm Hg for 4.5% of the time (SD, 16.3). After adjustment for covariates, CPP time index (between 50 and 70 mm Hg) was not associated with hospital mortality (odds ratio [OR], 1.2; 95% confidence interval [CI], 0.98-1.6; P= .079). The time indices for CPP ≥70 and <50 mm Hg were associated with decreased (OR, 0.66; 95%CI, 0.52-0.82; P< .0001) and increased (OR, 9.9; 95% CI, 1.4-69.6; P= .021) mortality, respectively. CONCLUSION: Cerebral perfusion pressure was greater than 70 mm Hg for most of the time. This level of CPP was associated with decreased hospital mortality.
PURPOSE: The aims of this study are to assess adherence to the Brain Trauma Foundation (BTF) cerebral perfusion pressure (CPP) guidelines and to determine if adherence is associated with mortality in patients who have a severe traumatic brain injury. MATERIALS AND METHODS: Retrospective cohort study of 127 patients admitted to one intensive care unit between 2006 and 2012. Adherence to BTF guidelines was measured as the time that the CPP was within 50 to 70 mm Hg divided by the total time of CPP monitoring (CPP time index). RESULTS: The percentage of time that the CPP was within the recommended range was 31.6% (SD, 22.2); CPP was greater than 70 mm Hg for 63.9% (SD, 26.2) of the time and less than 50 mm Hg for 4.5% of the time (SD, 16.3). After adjustment for covariates, CPP time index (between 50 and 70 mm Hg) was not associated with hospital mortality (odds ratio [OR], 1.2; 95% confidence interval [CI], 0.98-1.6; P= .079). The time indices for CPP ≥70 and <50 mm Hg were associated with decreased (OR, 0.66; 95%CI, 0.52-0.82; P< .0001) and increased (OR, 9.9; 95% CI, 1.4-69.6; P= .021) mortality, respectively. CONCLUSION: Cerebral perfusion pressure was greater than 70 mm Hg for most of the time. This level of CPP was associated with decreased hospital mortality.
Authors: Donald E Griesdale; Mypinder S Sekhon; David K Menon; Andrea Lavinio; Joseph Donnelly; Chiara Robba; Indeep S Sekhon; Andrew Taylor; William R Henderson; Alexis F Turgeon; Arun K Gupta Journal: Neurocrit Care Date: 2015-08 Impact factor: 3.210
Authors: Joseph Donnelly; Marek Czosnyka; Hadie Adams; Chiara Robba; Luzius A Steiner; Danilo Cardim; Brenno Cabella; Xiuyun Liu; Ari Ercole; Peter John Hutchinson; David Krishna Menon; Marcel J H Aries; Peter Smielewski Journal: Crit Care Med Date: 2017-09 Impact factor: 7.598
Authors: Anjni Patel; Mateus Mazorra Coelho Vieira; John Abraham; Nick Reid; Tu Tran; Kevin Tomecsek; João Ricardo N Vissoci; Stephanie Eucker; Charles J Gerardo; Catherine A Staton Journal: PLoS One Date: 2016-09-01 Impact factor: 3.240
Authors: Travis C Jackson; C Edward Dixon; Keri Janesko-Feldman; Vincent Vagni; Shawn E Kotermanski; Edwin K Jackson; Patrick M Kochanek Journal: Sci Rep Date: 2018-05-08 Impact factor: 4.379
Authors: Ofer Amram; Nadine Schuurman; Ian Pike; Natalie L Yanchar; Michael Friger; Paul B McBeth; Donald Griesdale Journal: Int J Environ Res Public Health Date: 2015-12-08 Impact factor: 3.390